Celldex Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.4M | 36k | 39.66 |
| 2023-09-30 | $1.0M | 37k | 27.52 |
| 2023-06-30 | $1.2M | 34k | 33.93 |
| 2023-03-31 | $1.6M | 45k | 35.98 |
| 2022-12-31 | $1.6M | 36k | 44.57 |
| 2022-09-30 | $942k | 34k | 28.11 |
| 2022-06-30 | $4.6M | 170k | 26.99 |
| 2022-03-31 | $2.5M | 75k | 34.05 |
| 2021-12-31 | $3.8M | 98k | 38.60 |
| 2021-09-30 | $2.4M | 45k | 54.00 |
| 2021-06-30 | $1.1M | 35k | 33.10 |
| 2021-03-31 | $50k | 2.4k | 20.76 |
| 2020-12-31 | $1.4M | 82k | 17.53 |
| 2020-09-30 | $5.8M | 394k | 14.83 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft